Skip to content

Innovative Modalities for Restoring Upper Limb Function Post Stroke

Innovative Modalities for Restoring Upper Limb Function Post Stroke

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01725659
Enrollment
35
Registered
2012-11-14
Start date
2001-09-30
Completion date
2009-12-31
Last updated
2012-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebrovascular Accident

Keywords

Stroke, electric stimulation, robotics, motor learning

Brief summary

PURPOSE. After stroke many patients are unable to engage in normal upper limb functional activities, which may restrict them from participation in meaningful life roles. For many, conventional rehabilitation does not restore upper limb function to a useful level. The purpose of this research is to investigate the benefits of three promising motor learning interventions: focused intensive, motor learning (FIML); 2) robotics and motor learning (ROB-ML); and 3) functional neuromuscular stimulation and motor learning (FNS-ML).

Interventions

OTHERMotor Learning

training of the hemiplegic upper limb with motor learning

OTHERRobotics

subjects perform training of hemiplegic arm using an upper extremity robot

OTHERsurface FES

subjects are provided with surface FES to the hemiplegic upper limb

Sponsors

Malcom Randall VA Medical Center
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* \>1 year post stroke no acute, uncontrolled medical condition single stroke

Exclusion criteria

* pacemaker other neurological condition more than one stroke

Design outcomes

Primary

MeasureTime frameDescription
Fugl Meyerafter 12 weeks of interventionimpairment measure of coordination of the upper limb

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026